Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Pricing Debate Must Be Framed As Trade Issue, Pfizer CEO Says

Executive Summary

The pharmaceutical industry needs to re-cast the global pricing and reimportation debate as a trade issue, Pfizer CEO Henry McKinnell told the Bear Stearns conference in New York City Sept. 8

You may also be interested in...



International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations

U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement

FDA Goes Global: Trade Talks Suggest Drug Prices Are Part Of Mission

FDA's involvement in trade negotiations with Australia is the latest sign that the agency's mission is evolving under Commissioner McClellan toward the once-taboo topic of pharmaceutical prices

International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations

U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement

Related Content

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel